How to Get Zetia (Ezetimibe) in Arizona

What Ezetimibe Is and When It Is Used

Ezetimibe reduces intestinal absorption of cholesterol. The current Zetia label lists a 10 mg tablet taken once daily. It can be used with a statin, or alone when additional LDL-cholesterol lowering therapy is not possible, as an adjunct to diet in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia 1.

Whether it is the right next medication depends on the person's cardiovascular risk, current LDL-C, response and tolerance to statins, other conditions, and treatment goal. The 2018 AHA/ACC cholesterol guideline and the 2022 ACC expert pathway describe ezetimibe as a commonly used nonstatin option in several higher-risk settings when additional LDL-C lowering is needed 4 5.

What the Clinical Trials Actually Show

The IMPROVE-IT trial enrolled 18,144 people after an acute coronary syndrome. At seven years, the primary composite cardiovascular endpoint occurred in 32.7% of the simvastatin-plus-ezetimibe group and 34.7% of the simvastatin-alone group, an absolute difference of 2.0 percentage points. The trial supports incremental benefit when ezetimibe was added to statin therapy in that specific high-risk population; it does not mean ezetimibe alone reduces every patient's risk by 6.4% 2.

SHARP randomized 9,270 people with chronic kidney disease to simvastatin plus ezetimibe or placebo and found a reduction in major atherosclerotic events. Because SHARP tested the combination rather than ezetimibe monotherapy, it should not be cited as proof that ezetimibe alone produced the entire outcome 3.

These distinctions matter for an authorization request: the most useful evidence is evidence that fits the member's diagnosis and planned regimen, not a trial name detached from its population and comparator.

Steps to Get Ezetimibe in Arizona

1. Choose an authorized clinician. Primary care clinicians, cardiologists, lipid specialists, and other prescribers can evaluate the need for ezetimibe within their scope.
2. Gather the current record. Bring the medication list, allergy history, prior statin doses and reactions, cardiovascular history, and recent lipid results.
3. Confirm the treatment goal. The clinician should know whether the aim is primary prevention, secondary prevention after cardiovascular disease, familial hypercholesterolemia, or another labeled use.
4. Check coverage before the prescription is filled. Search the exact plan formulary for ezetimibe and Zetia, then note prior authorization, quantity limits, and preferred pharmacy rules.
5. Complete any authorization request. The prescriber should answer the plan's actual criteria with the relevant lipid values, prior treatments, and rationale.
6. Confirm the pharmacy claim and follow-up plan. Ask what the first fill will cost and when the lipid response will be reassessed.

Telehealth Prescribing in Arizona

Arizona law recognizes telehealth and generally requires the standard of care that applies to an in-person setting. A telehealth service does not create a guarantee that a drug will be prescribed; the clinician still needs enough information to establish the indication and make a safe treatment decision. Arizona Revised Statutes § 36-3602

For a patient who already has a diagnosis, current lipid results, and a documented treatment history, telehealth may be a practical way to review therapy. A clinician may instead request an in-person examination or updated testing when the available record is incomplete or symptoms suggest another issue.

What Tests Are Usually Reviewed

A lipid panel is central because ezetimibe is used to lower LDL-C and the treatment response has to be measurable. The panel does not always need to be fasting; fasting status depends on the clinical question and triglyceride level. The earlier page incorrectly presented a fasting panel within 12 months as a universal legal prerequisite.

The current product label says to assess liver enzymes before starting Zetia when it is used with a statin, and thereafter when clinically indicated. That is different from saying every person taking ezetimibe alone needs a recurring liver panel on a fixed schedule. The label also says Zetia is not recommended in moderate to severe hepatic impairment 1.

Other testing is driven by the individual history. A clinician may investigate diabetes, thyroid disease, kidney disease, liver disease, or another secondary contributor to dyslipidemia when the presentation warrants it.

AHCCCS Coverage in 2026

The previous page's statement that “Arizona Medicaid does not cover ezetimibe” was false. The AHCCCS Acute and Long Term Care Drug List effective January 1, 2026 lists ezetimibe tablets in the intestinal cholesterol absorption inhibitor class as a preferred drug with prior authorization required 6.

AHCCCS also explains that its fee-for-service formulary is not the formulary for every contracted health-plan member. Members enrolled in an AHCCCS health plan should use that plan's current formulary and pharmacy instructions. AHCCCS formulary information

That yields a precise answer:

• AHCCCS fee-for-service: ezetimibe is listed, with prior authorization.
• AHCCCS managed-care plan: check the member's health-plan formulary and requirements.
• Brand Zetia versus generic ezetimibe: coverage can differ, so search both names.

Commercial Insurance and Medicare

Commercial and Medicare formularies can place brand and generic products differently. A formulary result should be matched to the exact dosage form and strength. If generic ezetimibe is covered but brand Zetia is not preferred, a brand request may need documentation explaining why the covered generic cannot be used.

Prior authorization criteria vary. Common evidence categories include the diagnosis, current LDL-C, maximally tolerated statin therapy, intolerance or contraindication, and the reason further lowering is needed. Do not assume a plan requires failure of a PCSK9 inhibitor before ezetimibe or that every PCSK9 request requires ezetimibe first; use the current written criteria for the requested drug.

Pharmacy Access and Cost

Ezetimibe is available from multiple generic manufacturers, but stock and network participation can vary. Before the prescription is sent, ask the pharmacy whether it stocks the prescribed product and whether it is preferred by the insurance plan.

There is no reliable statewide cash price. Online coupons change by pharmacy, quantity, manufacturer, and date. Compare:

• the plan price at an in-network pharmacy;
• a cash price without submitting insurance;
• a discount-card price; and
• a 30-day versus 90-day fill when the prescription and plan allow it.

A cash or coupon transaction is separate from an insurance claim and generally does not count toward the plan deductible or out-of-pocket maximum.

Safety and Interaction Review

The current label identifies several issues a prescriber should review:

• active liver disease or moderate to severe hepatic impairment;
• muscle symptoms, especially when ezetimibe is combined with a statin or fibrate;
• cyclosporine, which can increase ezetimibe exposure;
• fibrates and possible gallbladder effects; and
• bile acid sequestrants, which require separated administration timing.

The label advises taking ezetimibe at least two hours before or at least four hours after a bile acid sequestrant 1.